AstraZeneca agreed to a collaboration worth up to $555m in regulatory and commercial milestones with San Francisco–based Algen Biotechnologies, securing exclusive rights to develop and …
Read More
Singapore’s Nanyang Biologics (NYB), a company working at the intersection of biodiversity and artificial intelligence, is preparing to list on Nasdaq through a US$ 1.5 billion …
Read More
BigHat Biosciences, headquartered in San Mateo, California, has unveiled the Reccy Antibody Design Studio (RADS), a fully integrated platform combining machine learning with high-throughput experimental …
Read More
![[Interview] The Rise of Quantum Physics in …](/files/blog/20190715_222113.7097_Enric_Pharmacelera.png)
